TRAF6 and head and neck squamous cell carcinoma: Downstream IRAK1 signaling was suppressed through TRAF6, attenuating activation of NF-κB and MAPK and stimulating cancer cell death, thus highlighting the potential use of IRAK1 inhibitors in the treatment of HNSCC.